This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Sensitivity analysis
Sensitivity analysis was carried out using the method of single parameter variation.
Estimated benefits used in the economic analysis
For erythromycin, QALYs were 16.999, and for the comparator QALYs were 16.997; therefore the incremental QALYs per patient were 0.0002. For penicillin, QALYs were 16.996, and for the comparator QALYs were 16.997. Therefore incremental QALYs per patient were -0.0001. Benefits were not discounted. Outcome duration was life long and treatment side-effects were included.
Synthesis of costs and benefits
Intervention and cost durations were less than 1 year. Costs and benefits were not discounted. Incremental cost per QALY gained for antibiotic prophylaxis using erythromycin was 10,700; for antibiotic prophylaxis, using penicillin, the incremental costs were positive and the incremental benefits were negative.
The range of incremental cost per QALY for erythromycin was 1080(lowest value), there was positive incremental costs and negative incremental benefits for the highest value. For penicillin incremental costs were negative and incremental benefits were positive (lowest value); incremental costs were positive and incremental costs were negative for the highest value.
Sensitive parameters were probability of joint infection and case fatality rate from infection.
CRD Commentary
(This commentary was not written by CRD, but by the authors of the DH Register).
1) The study uses cohort data concerning the morbidity and mortality associated with dental infections haematologically transferred to the hip. There is no data on the efficacy of antibiotics to prevent this: evidence is taken from bacterial endocarditis prevention.
2) The medical evidence is highly uncertain and this is reflected by the wide range in the sensitivity analysis.
3) Normal life-expectancy is assigned to lives saved, this may be optimistic. 4) There were no health omissions.
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